D1000VFARMA (DMVF3) Main Indicators
Basic Data - DMVF3
Company | D1000VFARMA |
Corporate Name | D1000 VAREJO FARMA PARTICIPAÇÕES S.A. |
Registration Status | ATIVO |
Issuer Status | FASE OPERACIONAL |
Listing Segment | Novo Mercado |
Activity | A Companhia tem por objeto a participação. como sócia ou acionista. em outras sociedades do varejo farmacêutico. nacionais ou estrangeiras. |
Share | DMVF3 |
Quote Date | 09/18/2024 |
Share Type | ON |
Last Closing | R$ 6.73 |
Quotation Factor | 1 Share |
Financial Volume | R$ 349.72 thousand |
Last Statement | ITR - 06/30/2024 |
Sector | Saúde |
Subsector | Comércio e Distribuição |
Segment | Medicamentos e Outros Produtos |
Participation Indexes | IGC, IGNM, ITAG |
Updated 09/19/2024 |
Relative Prices - DMVF3
Price/Earnings | 12.60 |
Price/SBV | 0.39 |
Price/Net Sales | 0.18 |
Price/CFO | 2.17 |
Price/FCF | 3.42 |
Price/Total Assets | 0.21 |
Price/EBIT | 5.57 |
Price/Working Capital | 5.00 |
Price/NCAV | -0.49 |
EV/EBIT | 5.15 |
EV/EBITDA | 1.84 |
EV/Net Sales | 0.17 |
EV/CFO | 2.00 |
EV/FCF | 3.16 |
EV/Total Assets | 0.19 |
Company Market Cap | R$ 340.56 M |
Enterprise Value | R$ 314.86 M |
Current Financial Statement Date | 06/30/2024 |
Current Share Price | R$ 6.73 |
Share Price Date | 09/18/2024 |
Dividend Yield | 0.00% |
Updated 09/19/2024 |
Income Statement - DMVF3
Net Revenue | R$ 1.90 B |
Gross Result | R$ 601.76 M |
EBIT | R$ 61.09 M |
Depreciation and Amortization | - R$ 110.29 M |
EBITDA | R$ 171.38 M |
Net Profit | R$ 27.03 M |
Net Profit/Share | R$ 0.53 |
Updated 08/07/2024 |
Net Revenue | R$ 513.18 M |
Gross Result | R$ 167.80 M |
EBIT | R$ 22.47 M |
Depreciation and Amortization | - R$ 28.72 M |
EBITDA | R$ 51.19 M |
Net Profit | R$ 10.98 M |
Profit/Share | R$ 0.22 |
Updated 08/07/2024 |
Price and Volume Behavior - DMVF3
Lowest Price 52 weeks | R$ 4.13 |
Highest Price 52 weeks | R$ 8.38 |
Variation 2024 | 18.90% |
Variation 1 year | 32.22% |
Variation 2 years(total) | 52.61% |
Variation 2 years(yearly) | 23.43% |
Variation 3 years(total) | -2.04% |
Variation 3 years(yearly) | -0.68% |
Variation 4 years(total) | -32.70% |
Variation 4 years(yearly) | -9.42% |
Variation 5 years(total) | - |
Variation 5 years(yearly) | - |
Average Daily Volume (3 months) | R$ 576.72 thousand |
Updated 09/19/2024 |
Returns and Margins - DMVF3
Return on Initial Tangible Capital | 8.45% |
Return on Initial Invested Capital | 4.85% |
Pre-Tax Return on Initial Tangible Capital | 12.81% |
Pre-Tax Return on Initial Invested Capital | 7.35% |
Return on Initial Shareholder´s Equity | 3.16% |
Return on Initial Asset | 1.82% |
Gross Margin | 31.59% |
Net Margin | 1.42% |
EBIT Margin | 3.21% |
EBITDA Margin | 9.00% |
Initial Asset Turnover | 1.28 |
Financial Leverage | 1.87 |
Liabilities/Net Worth | 0.87 |
Net Debt/EBITDA | -0.15 |
Updated 08/07/2024 |
Balance Sheet - DMVF3
Cash and Cash Equivalents | R$ 48.65 M |
Total Assets | R$ 1.65 B |
Short-Term Debt | R$ 13.45 M |
Long-Term Debt | R$ 9.50 M |
Gross Debt | R$ 22.95 M |
Net Debt | - R$ 25.69 M |
Shareholder´s Equity | R$ 882.86 M |
Share Book Value | R$ 17.45 |
Common Shares | 50,603,000 |
Preferred Shares | 0 |
Total | 50,603,000 |
Common Shares in Treasury | 0 |
Preferred Shares in Treasury | 0 |
Total in Treasury | 0 |
Common Shares (Except Treasury) | 50,603,000 |
Preferred Shares (Except Treasury) | 0 |
Total (Except Treasury) | 50,603,000 |
Updated 08/07/2024 |
Cash Flow - DMVF3
Operating Cash Flow | R$ 157.25 M |
Cash Flow from Investments | - R$ 71.97 M |
Financing Cash Flow | - R$ 88.61 M |
Increase (Reduction) in Cash and Equivalents | - R$ 3.32 M |
Updated 08/07/2024 |
Operating Cash Flow | R$ 45.97 M |
Cash Flow from Investments | - R$ 20.63 M |
Financing Cash Flow | - R$ 29.19 M |
Increase (Reduction) in Cash and Equivalents | - R$ 3.84 M |
Updated 08/07/2024 |
Experimental - DMVF3
CAPEX 3 months | - R$ 16.10 M |
Free Cash Flow 3 months | R$ 29.88 M |
CAPEX 12 months | - R$ 57.70 M |
Free Cash Flow 12 months | R$ 99.55 M |
Updated 08/07/2024 |